4-(3-(4-[125I]Iodophenyl)-1,2,4-oxadiazol-5-yl)aniline

ID: ALA498844

PubChem CID: 44560738

Max Phase: Preclinical

Molecular Formula: C14H10IN3O

Molecular Weight: 363.16

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1ccc(-c2nc(-c3ccc([125I])cc3)no2)cc1

Standard InChI:  InChI=1S/C14H10IN3O/c15-11-5-1-9(2-6-11)13-17-14(19-18-13)10-3-7-12(16)8-4-10/h1-8H,16H2/i15-2

Standard InChI Key:  FQPAQISAGHRKKG-VLPIPSKASA-N

Molfile:  

     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -0.3591   -0.1485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2937   -0.6539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9768   -0.1899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7444    0.6051    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0802    0.6263    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6893   -0.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6914   -1.4247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4074   -1.8345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1217   -1.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1156   -0.5887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3991   -0.1827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0820   -0.5394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7862   -0.1060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5114   -0.4992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5336   -1.3255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8246   -1.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1023   -1.3614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2588   -1.7202    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    3.8390   -1.8275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  9 10  1  0
  5  1  2  0
 10 11  2  0
 11  6  1  0
  3  6  1  0
  1  2  1  0
 12 13  2  0
  6  7  2  0
 13 14  1  0
  2  3  2  0
 14 15  2  0
  7  8  1  0
 15 16  1  0
  3  4  1  0
 16 17  2  0
 17 12  1  0
  1 12  1  0
  8  9  2  0
 15 18  1  0
  4  5  1  0
  9 19  1  0
M  ISO  1  18 125
M  END

Associated Targets(non-human)

Kidney (1278 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Heart (1016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Stomach (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (1764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Spleen (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pancreas (361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Intestine (514 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.16Molecular Weight (Monoisotopic): 362.9869AlogP: 3.59#Rotatable Bonds: 2
Polar Surface Area: 64.94Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.45CX LogP: 4.31CX LogD: 4.31
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.56Np Likeness Score: -1.73

References

1. Ono M, Haratake M, Saji H, Nakayama M..  (2008)  Development of novel beta-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole.,  16  (14): [PMID:18550375] [10.1016/j.bmc.2008.05.054]

Source